Patients React To The Redesigned My Essentia Health Mychart Interface
参考文献：A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction.
MyChart Patient Portal | Meritus Health
